ORTHOCON

Irvington, United States Founded: 2005 • Age: 21 yrs Acquired By Abyrx
Resorbable hemostatic bone putty is developed to stop surgical bleeding.
Request Access

About ORTHOCON

ORTHOCON is a company based in Irvington (United States) founded in 2005 was acquired by Abyrx in April 2013.. ORTHOCON has raised $27.16 million across 2 funding rounds from investors including Canaan, Abyrx and BB Biotech Ventures. ORTHOCON offers products and services including Hemostatic Bone Putty, MONTAGE, and Water-Soluble Hemostatic Bone Putty. ORTHOCON operates in a competitive market with competitors including Stryker, Zimmer Biomet, Humacyte, Smith & Nephew and NuVasive, among others.

  • Headquarter Irvington, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Abyrx, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $27.16 M (USD)

    in 2 rounds

  • Latest Funding Round
    $2.16 M (USD), Series B

    Sep 30, 2010

  • Investors
    Canaan

    & 3 more

  • Employee Count
    Employee Count
  • Acquired by
    Abyrx

    (Apr 24, 2013)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of ORTHOCON

ORTHOCON offers a comprehensive portfolio of products and services, including Hemostatic Bone Putty, MONTAGE, and Water-Soluble Hemostatic Bone Putty. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Provides hemostasis for bone surfaces during surgical procedures.

Settable putty that adheres to bleeding bone in surgical applications.

Hemostatic solution for easy application in bone surgery.

Funding Insights of ORTHOCON

ORTHOCON has successfully raised a total of $27.16M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $2.16 million completed in September 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series B — $2.2M
  • First Round

    (07 Apr 2009)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2010 Amount Series B - ORTHOCON Valuation

investors

Apr, 2009 Amount Series B - ORTHOCON Valuation Canaan , ProQuest Investments
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in ORTHOCON

ORTHOCON has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Canaan, Abyrx and BB Biotech Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Canaan is recognized as an early-stage venture capital firm.
Founded Year Domain Location
-
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by ORTHOCON

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - ORTHOCON

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Orthocon Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of ORTHOCON

ORTHOCON operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Stryker, Zimmer Biomet, Humacyte, Smith & Nephew and NuVasive, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
3D-printed orthopedic products are manufactured for medical applications.
domain founded_year HQ Location
Medical devices for multiple health purposes are manufactured.
domain founded_year HQ Location
Human tissue-based products are developed for vascular disease applications.
domain founded_year HQ Location
Manufacturer of knee, hip and shoulder joint replacements
domain founded_year HQ Location
Smart surgical devices for spinal surgery are developed.
domain founded_year HQ Location
Developer of devices for spine surgery
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Orthocon

Frequently Asked Questions about ORTHOCON

When was ORTHOCON founded?

ORTHOCON was founded in 2005 and raised its 1st funding round 4 years after it was founded.

Where is ORTHOCON located?

ORTHOCON is headquartered in Irvington, United States. It is registered at Irvington, New Jersey, United States.

Is ORTHOCON a funded company?

ORTHOCON is a funded company, having raised a total of $27.16M across 2 funding rounds to date. The company's 1st funding round was a Series B of $25M, raised on Apr 07, 2009.

What does ORTHOCON do?

Orthocon was founded in 2005 and is based in Irvington, United States. Operations focus on medical therapeutics within the orthopaedic and spine surgery sectors. Resorbable products, including the FDA-approved HEMASORB Bone Hemostat Matrix, are created to address active bone bleeding. This synthetic matrix is applied directly to sites and is substantially resorbed within 30 days, supporting surgical procedures.

Who are the top competitors of ORTHOCON?

ORTHOCON's top competitors include Stryker, Humacyte and NuVasive.

What products or services does ORTHOCON offer?

ORTHOCON offers Hemostatic Bone Putty, MONTAGE, and Water-Soluble Hemostatic Bone Putty.

Who are ORTHOCON's investors?

ORTHOCON has 4 investors. Key investors include Canaan, Abyrx, BB Biotech Ventures, and ProQuest Investments.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available